Shandong Xinhua Pharmaceutical Company Limited provided earnings guidance for the nine months ended September 30, 2017. For the nine months, the company expects to reported net profits attributable to the equity holders of the company of approximately from RMB 152,000,000 to RMB 196,000,000 and basic earnings per share of RMB 0.33 to RMB 0.43.